Business Standard

Divi's Labs m-cap crosses Rs 1 trillion; stock zooms 109% in CY 2020 so far

Currently, Divis Labs stands at the 30th position among companies having market-cap of over Rs 1 trillion.

paracetamol, pharma, drugs, medicine, health
Premium

ICICI Securities recently initiated coverage on the stock with ADD rating and target price of Rs 3,960.

SI Reporter Mumbai
Divi’s Laboratories entered the elite club of companies with a market capitalisation (market-cap) of Rs 1 trillion after the firm's stock price hit a new high of Rs 3,832, up 3 per cent, on Thursday. 

The stock of the pharmaceutical company surpassed its previous high of Rs 3,763.40, touched on December 10, 2020.

At 10:05 am, Divi’s Labs' market-capitalisation stood at Rs 1.01 trillion, exchange data show. 

Currently, Divis Labs stands at the 30th position among companies having market-cap of over Rs 1 trillion. It is the second most valued pharma company after Sun Pharmaceutical Industries, which has market-cap of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in